Rice Hall James & Associates LLC Makes New Investment in Corteva, Inc. $CTVA

Rice Hall James & Associates LLC bought a new position in Corteva, Inc. (NYSE:CTVA) in the 2nd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor bought 7,876 shares of the company’s stock, valued at approximately $667,000.

Other large investors have also modified their holdings of the company. JPL Wealth Management LLC purchased a new stake in shares of Corteva during the 3rd quarter valued at about $25,000. Garton & Associates Financial Advisors LLC purchased a new position in Corteva in the 4th quarter worth approximately $27,000. Bank of Jackson Hole Trust acquired a new stake in Corteva in the fourth quarter valued at approximately $28,000. Cornerstone Financial Management LLC acquired a new stake in Corteva in the fourth quarter valued at approximately $29,000. Finally, Elevation Wealth Partners LLC raised its stake in shares of Corteva by 334.6% during the second quarter. Elevation Wealth Partners LLC now owns 339 shares of the company’s stock valued at $29,000 after purchasing an additional 261 shares during the period. Institutional investors and hedge funds own 81.54% of the company’s stock.

Analyst Ratings Changes

Several brokerages have recently weighed in on CTVA. Oppenheimer upped their target price on shares of Corteva from $89.00 to $95.00 and gave the company an “outperform” rating in a research note on Thursday, July 23rd. Citigroup lifted their price target on shares of Corteva from $85.00 to $86.00 and gave the stock a “neutral” rating in a research note on Monday, August 3rd. Rothschild & Co Redburn upped their price objective on shares of Corteva from $80.00 to $90.00 and gave the company a “neutral” rating in a research report on Wednesday, April 29th. Jefferies Financial Group raised their target price on Corteva from $95.00 to $97.00 in a research note on Thursday, May 7th. Finally, Royal Bank Of Canada lifted their target price on Corteva from $97.00 to $103.00 and gave the stock an “outperform” rating in a research report on Tuesday, July 21st. Fourteen investment analysts have rated the stock with a Buy rating and nine have issued a Hold rating to the company’s stock. According to MarketBeat.com, Corteva currently has an average rating of “Moderate Buy” and a consensus price target of $91.50.

Corteva Price Performance

Shares of NYSE CTVA opened at $77.97 on Wednesday. The company has a current ratio of 1.52, a quick ratio of 1.10 and a debt-to-equity ratio of 0.07. The company has a market capitalization of $52.02 billion, a price-to-earnings ratio of 51.64, a price-to-earnings-growth ratio of 2.35 and a beta of 0.57. Corteva, Inc. has a twelve month low of $60.53 and a twelve month high of $90.97. The business has a 50 day simple moving average of $81.84 and a 200-day simple moving average of $80.12.

Corteva (NYSE:CTVA) last announced its quarterly earnings data on Thursday, July 30th. The company reported $2.30 earnings per share (EPS) for the quarter, topping the consensus estimate of $2.24 by $0.06. The firm had revenue of $6.38 billion for the quarter, compared to analysts’ expectations of $6.60 billion. Corteva had a return on equity of 10.18% and a net margin of 5.66%.The firm’s revenue for the quarter was down 1.2% on a year-over-year basis. During the same period last year, the business posted $2.20 earnings per share. Corteva has set its FY 2026 guidance at 3.600-3.800 EPS. As a group, equities research analysts expect that Corteva, Inc. will post 3.72 earnings per share for the current year.

Corteva Announces Dividend

The firm also recently declared a quarterly dividend, which will be paid on Tuesday, September 15th. Stockholders of record on Tuesday, September 1st will be given a $0.18 dividend. This represents a $0.72 dividend on an annualized basis and a dividend yield of 0.9%. The ex-dividend date is Tuesday, September 1st. Corteva’s dividend payout ratio (DPR) is presently 47.68%.

Corteva Profile

Corteva, Inc (NYSE: CTVA) is an independent global agriculture company that was established as a publicly traded firm in mid‑2019 following the separation of the agriculture businesses from DowDuPont. The company focuses on delivering technologies and products that help farmers increase productivity and manage crop health. Corteva’s operations combine seed genetics, crop protection chemistries, digital tools and biological solutions to address the full cycle of crop production.

Core business activities include research and development of seed genetics and trait technologies, formulation and sale of crop protection products (such as herbicides, insecticides and fungicides), and the development of seed treatments and biologicals.